These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients with acute myocardial infarction. Lee HJ; Park TK; Song YB; Choi YJ; Yu CW; Yang JH; Hahn JY; Choi SH; Choi RK; Choi JH; Park JS; Kim JS; Kim TH; Jang HJ; Lee SH; Shim WH; Roh YM; Gwon HC Int J Cardiol; 2015 Mar; 183():190-7. PubMed ID: 25668147 [TBL] [Abstract][Full Text] [Related]
24. Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial). Maeng M; Christiansen EH; Raungaard B; Kahlert J; Terkelsen CJ; Kristensen SD; Carstensen S; Aarøe J; Jensen SE; Villadsen AB; Lassen JF; Thim T; Eftekhari A; Veien KT; Hansen KN; Junker A; Bøtker HE; Jensen LO; JACC Cardiovasc Interv; 2019 Apr; 12(7):624-633. PubMed ID: 30947936 [TBL] [Abstract][Full Text] [Related]
31. Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions: a randomized Long Drug-Eluting Stent V trial. Lee JY; Park DW; Kim YH; Ahn JM; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Yang TH; Lee BK; Lee NH; Yang JY; Shin WY; Park HS; Kim KS; Hur SH; Lee SY; Park JS; Choi YS; Lee SU; Her SH; Park SJ Circ Cardiovasc Interv; 2014 Jun; 7(3):322-9. PubMed ID: 24823426 [TBL] [Abstract][Full Text] [Related]
32. Comparative Effectiveness and Safety of Polymer-Free Biolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent in All-Comer Patients Who Underwent Percutaneous Coronary Interventions. Pepe M; Biondi-Zoccai G; Corcione N; Nestola PL; Ferraro P; Morello A; Conte S; Prati F; Bianchi FP; Bortone AS; Giordano A Am J Cardiol; 2019 Jul; 124(2):195-204. PubMed ID: 31103132 [TBL] [Abstract][Full Text] [Related]
33. Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial. Pilgrim T; Piccolo R; Heg D; Roffi M; Tüller D; Muller O; Moarof I; Siontis GCM; Cook S; Weilenmann D; Kaiser C; Cuculi F; Hunziker L; Eberli FR; Jüni P; Windecker S Lancet; 2018 Sep; 392(10149):737-746. PubMed ID: 30170848 [TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Biodegradable Polymer-biolimus-eluting Stents (BP-BES) Compared with Durable Polymer-everolimus-eluting Stents (DP-EES) in Patients Undergoing Complex Percutaneous Coronary Intervention. Song PS; Park KT; Kim MJ; Jeon KH; Park JS; Choi RK; Song YB; Choi SH; Choi JH; Lee SH; Gwon HC; Jeong JO; Im ES; Kim SW; Chun WJ; Oh JH; Hahn JY Korean Circ J; 2019 Jan; 49(1):69-80. PubMed ID: 30468035 [TBL] [Abstract][Full Text] [Related]
35. A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial. Gao RL; Xu B; Lansky AJ; Yang YJ; Ma CS; Han YL; Chen SL; Li H; Zhang RY; Fu GS; Yuan ZY; Jiang H; Huo Y; Li W; Zhang YJ; Leon MB; EuroIntervention; 2013 May; 9(1):75-83. PubMed ID: 23685298 [TBL] [Abstract][Full Text] [Related]